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ABSTRACT
Gestational trophoblastic neoplasia (GTN) is a highly responsive to chemotherapy, 
but sometimes can be resistant, or relapse and require salvage chemotherapy with or 
without surgery.  We use descriptive studies with case series to determine prognosis 
patient GTN with chemotherapy resistant manage with surgical procedure in Dr Sardjito 
General Hospital, Yogyakarta. GTN-resistant chemotherapy patients that undergoing 
hysterectomy showed significant decreases in hCG levels. Hysterectomy also help us 
to stop vaginal bleeding. However, complications from continuous bleeding can worsen 
patient condition. The decision to take a hysterectomy action varies depending on the 
patient’s condition. At the Dr Sardjito General hospital, the patient was diagnosed with 
the fastest hysterectomy within the first 12 hours of treatment due to continuous bleeding, 
and shortly after 4 years of treatment with 5 different types of chemotherapy.
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